Evrofarma SA (EVROF.AT)
EUR 1.63
(0.93%)
EUR 1.63
(0.93%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.65 Million EUR | 170.54% |
| 2022 | 1.35 Million EUR | 484.85% |
| 2021 | 231 Thousand EUR | -61.11% |
| 2020 | 594 Thousand EUR | -62.74% |
| 2019 | 1.59 Million EUR | -15.08% |
| 2018 | 1.87 Million EUR | 9.89% |
| 2017 | 1.7 Million EUR | 41.16% |
| 2016 | 1.21 Million EUR | -47.14% |
| 2015 | 2.28 Million EUR | 151.54% |
| 2014 | 910 Thousand EUR | 10.17% |
| 2013 | 826 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.72 Million EUR | 0.0% |
| 2023 Q3 | 707 Thousand EUR | -36.9% |
| 2023 FY | 3.65 Million EUR | 170.54% |
| 2023 Q1 | 1.12 Million EUR | 27.47% |
| 2023 Q2 | 1.12 Million EUR | 0.0% |
| 2023 Q4 | 707 Thousand EUR | 0.0% |
| 2022 Q4 | 879 Thousand EUR | 0.0% |
| 2022 Q3 | 879 Thousand EUR | 253.01% |
| 2022 Q1 | 249 Thousand EUR | 160.58% |
| 2022 FY | 1.35 Million EUR | 484.85% |
| 2022 Q2 | 249 Thousand EUR | 0.0% |
| 2021 FY | 231 Thousand EUR | -61.11% |
| 2021 Q1 | 526.5 Thousand EUR | 1132.35% |
| 2021 Q4 | -411 Thousand EUR | 0.0% |
| 2021 Q2 | 723 Thousand EUR | 37.32% |
| 2021 Q3 | -411 Thousand EUR | -156.85% |
| 2020 Q4 | -51 Thousand EUR | -119.43% |
| 2020 FY | 594 Thousand EUR | -62.74% |
| 2020 Q2 | 555 Thousand EUR | 16.72% |
| 2020 Q1 | 475.5 Thousand EUR | 38.63% |
| 2020 Q3 | 262.5 Thousand EUR | -52.7% |
| 2019 Q2 | 1.25 Million EUR | 63.96% |
| 2019 FY | 1.59 Million EUR | -15.08% |
| 2019 Q4 | 343 Thousand EUR | 3.94% |
| 2019 Q3 | 330 Thousand EUR | -73.62% |
| 2019 Q1 | 763 Thousand EUR | 174.95% |
| 2018 Q3 | 277.5 Thousand EUR | -57.89% |
| 2018 FY | 1.87 Million EUR | 9.89% |
| 2018 Q4 | 277.5 Thousand EUR | 0.0% |
| 2018 Q2 | 659 Thousand EUR | 0.0% |
| 2018 Q1 | 659 Thousand EUR | 39.62% |
| 2017 Q2 | 413 Thousand EUR | 0.0% |
| 2017 FY | 1.7 Million EUR | 41.16% |
| 2017 Q3 | 472 Thousand EUR | 14.29% |
| 2017 Q4 | 472 Thousand EUR | 0.0% |
| 2017 Q1 | 413 Thousand EUR | 52.12% |
| 2016 FY | 1.21 Million EUR | -47.14% |
| 2016 Q2 | 535.5 Thousand EUR | 0.0% |
| 2016 Q1 | 535.5 Thousand EUR | 55.67% |
| 2016 Q4 | 271.5 Thousand EUR | 0.0% |
| 2016 Q3 | 271.5 Thousand EUR | -49.3% |
| 2015 Q4 | 344 Thousand EUR | -40.89% |
| 2015 FY | 2.28 Million EUR | 151.54% |
| 2015 Q3 | 582 Thousand EUR | -32.87% |
| 2015 Q2 | 867 Thousand EUR | 8.38% |
| 2015 Q1 | 800 Thousand EUR | 36.52% |
| 2014 FY | 910 Thousand EUR | 10.17% |
| 2014 Q2 | 48 Thousand EUR | -66.2% |
| 2014 Q3 | 729 Thousand EUR | 1418.75% |
| 2014 Q4 | 586 Thousand EUR | -19.62% |
| 2014 Q1 | 142 Thousand EUR | 184.0% |
| 2013 Q2 | 313 Thousand EUR | 1020.59% |
| 2013 Q3 | 497 Thousand EUR | 58.79% |
| 2013 Q1 | -34 Thousand EUR | 0.0% |
| 2013 FY | 826 Thousand EUR | 0.0% |
| 2013 Q4 | 50 Thousand EUR | -89.94% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 3 Million EUR | -21.774% |
| Kri-Kri Milk Industry S.A. | 39.21 Million EUR | 90.678% |
| Loulis Food Ingredients S.A. | 7.49 Million EUR | 51.265% |